Cases 21 - 30 of 63
ABERDEEN CANADA FUNDS-GLOBAL EQUITY FUND et al v. PERRIGO COMPANY PLC et al
as 2:2019cv06560
Plaintiff:
Aberdeen Global Equity Fund, a series of Aberdeen Funds, Desjardins Global Equity Value Fund, Aberdeen Life Global (ex UK) Equity Fund and others
Defendant:
JUDY L. BROWN, PERRIGO COMPANY PLC and JOSEPH C PAPA
Cause Of Action: 12 U.S.C. § 22
OZ MASTER FUND, LTD. et al v. PERRIGO CO., PLC et al
as 2:2019cv04900
Plaintiff:
OZ ENHANCED MASTER FUND, LTD. and OZ MASTER FUND, LTD.
Defendant:
PERRIGO CO., PLC, JOSEPH PAPA and JUDY BROWN
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. PERRIGO PHARMA INTERNATIONAL DAC et al
as 3:2018cv17518
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
PERRIGO PHARMA INTERNATIONAL DAC and PERRIGO CO. PLC
Cause Of Action: 35 U.S.C. § 271
WCM ALTERNATIVES: EVENT-DRIVEN FUND et al v. PERRIGO CO., PLC et al
as 2:2018cv16204
Plaintiff:
THE MERGER FUND VL, JNL/WESTCHESTER CAPITAL EVENT DRIVEN FUND, WCM ALTERNATIVES: EVENT-DRIVEN FUND and others
Defendant:
PERRIGO CO., PLC, JOSEPH PAPA and JUDY BROWN
ADAPT PHARMA OPERATIONS LIMITED et al v. PERRIGO UK FINCO LIMITED PARTNERSHIP
as 2:2018cv16987
Plaintiff:
ADAPT PHARMA OPERATIONS LIMITED, ADAPT PHARMA LIMITED, ADAPT PHARMA INC. and others
Defendant:
PERRIGO UK FINCO LIMITED PARTNERSHIP
Cause Of Action: 15 U.S.C. § 1126
ADAPT PHARMA OPERATIONS LIMITED et al v. PERRIGO UK FINCO LIMITED PARTNERSHIP
as 2:2018cv15287
Plaintiff:
ADAPT PHARMA OPERATIONS LIMITED, ADAPT PHARMA LIMITED, ADAPT PHARMA INC. and others
Defendant:
PERRIGO UK FINCO LIMITED PARTNERSHIP
Cause Of Action: 15 U.S.C. § 1126
NATIONWIDE MUTUAL FUNDS, on behalf of its series NATIONWIDE GENEVA MID CAP GROWTH FUND and NATIONWIDE S&P 500 INDEX FUND et al v. PERRIGO COMPANY PLC et al
as 2:2018cv15382
Plaintiff:
NATIONWIDE MUTUAL FUNDS, on behalf of its series NATIONWIDE GENEVA MID CAP GROWTH FUND and NATIONWIDE S&P 500 INDEX FUND and NATIONWIDE VARIABLE INSURANCE TRUST, on behalf of its series NVIT DYNAMIC U.S. GROWTH FUND, NVIT MULTI-MANAGER LARGE CAP VALUE FUND, NVIT S&P 500 INDEX FUND, and TEMPLETON NVIT INTERNATIONAL VALUE FUN
Defendant:
JUDY L. BROWN, JOSEPH C. PAPA and PERRIGO COMPANY PLC
Cause Of Action: 15 U.S.C. § 77
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. PERRIGO PHARMA INTERNATIONAL DAC et al
as 3:2018cv14207
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
PERRIGO PHARMA INTERNATIONAL DAC and PERRIGO CO. PLC
Cause Of Action: 35 U.S.C. § 271
PERRIGO RESEARCH & DEVELOPMENT COMPANY v. GLAXOSMITH CONSUMER HEALTHCARE LP et al
as 3:2018cv11835
Defendant:
GLAXOSMITHKLEIN LLC and GLAXOSMITHKLINE CONSUMER HEALTHCARE, L.P.
Plaintiff:
PERRIGO RESEARCH & DEVELOPMENT COMPANY,
Cause Of Action: 15 U.S.C. § 1126
PERRIGO RESEARCH AND DEVELOPMENT COMPANY et al v. RECKITT BENCKISER, LLC
as 1:2018cv09535
Plaintiff:
PERRIGO RESEARCH AND DEVELOPMENT COMPANY and PERRIGO COMPANY
Defendant:
RECKITT BENCKISER, LLC
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
